Neurosense Therapeutics (NRSN) CEO Issues Q3 2023 Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: NRSN) | Delayed: 3.07 -0.1 (3.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.17 | 52 Week High | $ | |||
| Open | $3.06 | 52 Week Low | $ | |||
| Day High | $3.24 | P/E | N/A | |||
| Day Low | $3.06 | EPS | $ | |||
| Volume | 9,705 | |||||
